4.7 Article

Vancomycin-decorated microbubbles as a theranostic agent for Staphylococcus aureus biofilms

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 609, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.ijpharm.2021.121154

Keywords

Biofilm; Sonobactericide; Targeted microbubble; Theranostic; Ultrasound; Vancomycin

Funding

  1. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [805308]
  2. Interdisciplinary Thematic Institute (ITI) InnoVec (Innovative Vectorization of Biomolecules, IdEx) [ANR-10-IDEX-0002]
  3. SFRI [ANR-20-SFRI-0012]
  4. European Research Council (ERC) [805308] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

The study confirmed the successful incorporation of vancomycin into microbubble lipid shell and demonstrated that vancomycin-decorated microbubbles significantly bound to biofilms and remained bound under shear stress conditions. Upon ultrasound exposure, the area of biofilm was reduced by up to 28%, supporting the potential of vancomycin-decorated microbubbles as a new theranostic tool for S. aureus biofilm infections allowing for specific bacterial detection and disruption.
Bacterial biofilms are a huge burden on our healthcare systems worldwide. The lack of specificity in diagnostic and treatment possibilities result in difficult-to-treat and persistent infections. The aim of this in vitro study was to investigate if microbubbles targeted specifically to bacteria in biofilms could be used both for diagnosis as well for sonobactericide treatment and demonstrate their theranostic potential for biofilm infection management. The antibiotic vancomycin was chemically coupled to the lipid shell of microbubbles and validated using mass spectrometry and high-axial resolution 4Pi confocal microscopy. Theranostic proof-of-principle was investigated by demonstrating the specific binding of vancomycin-decorated microbubbles (vMB) to statically and flow grown Staphylococcus aureus (S. aureus) biofilms under increasing shear stress flow conditions (0-12 dyn/cm2), as well as confirmation of microbubble oscillation and biofilm disruption upon ultrasound exposure (2 MHz, 250 kPa, and 5,000 or 10,000 cycles) during flow shear stress of 5 dyn/cm2 using time-lapse confocal microscopy combined with the Brandaris 128 ultra-high-speed camera. Vancomycin was successfully incorporated into the microbubble lipid shell. vMB bound significantly more often than control microbubbles to biofilms, also in the presence of free vancomycin (up to 1000 mu g/mL) and remained bound under increasing shear stress flow conditions (up to 12 dyn/cm2). Upon ultrasound insonification biofilm area was reduced of up to 28%, as confirmed by confocal microscopy. Our results confirm the successful production of vMB and support their potential as a new theranostic tool for S. aureus biofilm infections by allowing for specific bacterial detection and biofilm disruption.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available